BioCryst Pharmaceuticals, Inc. logo BCRX - BioCryst Pharmaceuticals, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 25
HOLD 4
SELL 0
STRONG
SELL
0
| PRICE TARGET: $16.86 DETAILS
HIGH: $25.00
LOW: $8.00
MEDIAN: $15.00
CONSENSUS: $16.86
UPSIDE: 103.38%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994
Revenue
Revenue 874.8 450.7 331.4 270.8 157.2 17.8 48.8 20.7 25.2 26.4 48.3 13.6 17.3 26.3 19.6 63.5 74.6 56.6 71.2 6.2 0.2 0.3 1.6 1.8 11.2 3.3 2.5 6.4 1 2.7 0.2 0.7
Cost of Revenue 19.1 12.5 4.7 6.6 7.3 1.7 4.1 0.5 1.7 2.7 1.9 0.1 0.1 0.1 0 0.1 4.5 0 0 0 0 0 0 0 0 0 (0.5) (0.5) (0.6) 7.1 6.5 5
Gross Profit 855.8 438.2 326.8 264.2 149.9 16.1 44.7 20.2 23.5 23.7 46.4 13.5 17.2 26.2 19.6 63.4 70.0 56.6 71.2 6.2 0.2 0.3 1.6 1.8 11.2 3.3 3 6.9 1.6 (4.4) (6.3) (4.3)
Operating Expenses
R&D Expenses 166.1 174.6 216.6 253.3 208.8 123.0 107.1 84.9 67.0 61.0 72.8 51.8 42.7 51.5 56.9 82.5 72.3 73.3 94.1 47.1 23.6 18.9 11.5 15.5 13.1 9.6 7.7 9.3 10.6 0 0 0
SG&A Expenses 348.6 266.1 213.9 159.4 118.8 67.9 37.1 29.5 13.9 11.3 13.0 7.5 5.2 6.8 12.3 14.2 11.5 10.4 9.5 6.1 3.7 3.2 2.8 2.9 3.1 3.6 2.9 3.1 2.7 2.7 2.2 1.9
Other Expenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0 0 0 0 0.5 0.5 0.6 0.5 0.6 0.6
Operating Expenses 514.8 440.8 430.5 412.7 327.6 190.9 144.2 114.4 80.9 72.3 85.8 59.3 48.0 58.3 69.2 96.7 83.8 83.7 103.5 53.2 27.3 22.1 14.3 18.3 16.1 13.1 11.1 12.9 13.9 3.2 2.8 2.5
Operating Income
Operating Income 341.0 (2.5) (103.7) (148.4) (177.7) (174.8) (99.5) (94.2) (57.4) (48.6) (39.4) (45.8) (30.7) (33.9) (49.6) (33.2) (13.7) (27.2) (32.3) (47.0) (27.2) (21.8) (12.7) (16.6) (5.0) (9.8) (8.1) (6) (12.3) (7.6) (9.1) (6.8)
Interest Expense 78.9 98.5 108.2 99.1 59.3 14.5 11.9 9.2 8.6 6.5 5.2 5.0 4.8 4.7 3.8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest Income 10.7 14.7 15.8 5.1 0.1 9.4 1.9 2.3 1.0 0.8 0.5 0.1 0.1 0.2 0.4 0.5 0.3 2.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Profitability
EBITDA 347.7 12.8 (116.3) (143.9) (121.7) (167.6) (96.3) (90.4) (56.5) (48.2) (37.6) (40.0) (25.0) (33.8) (52.3) (31.6) (11.8) (23.1) (27.7) (42.8) (25.2) (20.1) (12.6) (17.5) (3.9) (9.2) (7.6) (5.5) (11.7) (8.2) (8.5) (6.2)
EBIT 346.3 11.6 (118.0) (145.3) (122.5) (168.3) (97.0) (92.1) (57.2) (48.7) (37.8) (40.2) (25.3) (34.4) (53.2) (33.9) (13.7) (27.2) (32.3) (47.0) (27.2) (21.8) (13.7) (18.7) (5.0) (9.8) (8.1) (6) (12.3) (8.7) (9.1) (6.8)
Income Before Tax 267.4 (87.0) (226.2) (244.4) (181.8) (182.8) (108.9) (101.3) (65.8) (55.1) (43.0) (45.2) (30.1) (39.1) (56.9) (33,853.2) (13.5) (24.7) (29.1) (26,098.8) (26,098.8) (21,104.1) (12,700.1) (16,928.7) (4,986.0) (11,577.8) (6.9) (4.7) (10.6) 0 (8.4) 0
Income Tax Expense 3.5 1.9 0.3 2.7 2.3 0 0 0 0 0 0 0 0 0 0 500.8 (1.6) (0.0) 0.0 (26,055.2) 1,077.0 (0.6) (12,687.4) 0.4 (4,981.0) (11,566.3) (2.8) (1.2) 0 0.1 (0.5) 0.1
Net Income 263.9 (88.9) (226.5) (247.1) (184.1) (182.8) (108.9) (101.3) (65.8) (55.1) (43.0) (45.2) (30.1) (39.1) (56.9) (32.7) (13.5) (24.7) (29.1) (43.6) (26.1) (21.1) (12.7) (16.9) (5.0) (11.6) (5.3) (4.8) (10.6) (7.7) (8.6) (6.9)
Per Share Data
EPS (Basic) 1.26 -0.43 -1.18 -1.33 -1.03 -1.09 -0.94 -0.98 -0.78 -0.75 -0.59 -0.68 -0.55 -0.79 -1.26 -0.73 -0.35 -0.65 -0.89 -1.50 -1.01 -1.00 -0.72 -0.96 -0.28 -0.66 -0.34 -0.34 -0.77 -0.69 -0.96 -1.02
EPS (Diluted) 1.21 -0.43 -1.18 -1.33 -1.03 -1.09 -0.94 -0.98 -0.78 -0.75 -0.59 -0.68 -0.55 -0.79 -1.26 -0.73 -0.35 -0.65 -0.89 -1.50 -1.01 -1.00 -0.72 -0.96 -0.28 -0.61 -0.34 -0.34 -0.77 -0.69 -0.96 -1.02
Shares Outstanding 209.9 206.7 192.2 185.9 179.1 167.3 115.6 103.2 84.5 73.7 72.9 66.8 55.2 49.5 45.1 44.6 38.9 38.1 32.8 29.1 25.7 21.2 17.7 17.6 17.6 17.5 15.4 14.1 13.8 11.2 9.0 6.8
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2009 2008 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994
Current Assets
Cash & Cash Equivalents 89.7 104.9 110.6 304.8 504.4 272.1 114.2 26.7 50.3 22.1 41.1 22.3 8.8 11.9 13.8 18.9 8.5 8.6 12.3 3.8 3.6 6.1 2.7
Short-Term Investments 185.0 216.1 278.3 119.5 3.2 28.2 22.1 77.7 64.1 32.5 27.8 39.2 14.3 8.1 10.6 13.1 16.2 14.5 0 0 0 0 0
Net Receivables 106.8 79.1 57.0 50.6 29.4 8.6 22.1 4.3 6.1 8.8 33.7 12.0 0 0 0 0 0 0 0 0 0 0 0
Inventory 5.4 8.1 28.7 27.5 15.8 7.0 0 1.6 (37.8) 0.5 6.3 (13,494.7) 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 17.4 13.8 21.3 14.1 3.3 2.2 1.6 1.5 3.5 1.6 1.0 0.4 0 0 0 0 1.1 1.5 10.6 15.9 24.5 5.6 8.4
Total Current Assets 404.3 422.0 496.0 516.5 566.1 323.8 164.3 114.4 125.4 67.0 111.0 75.0 23.9 20.7 24.9 32.4 25.8 24.6 22.9 19.7 28.1 11.7 11.1
Non-Current Assets
Property, Plant & Equipment 19.0 19.8 20.9 8.6 15.2 7.1 7.3 9.1 9.5 9.9 3.9 4.9 2.8 3.5 4.6 5.4 3.8 1.8 1.4 1.6 1.1 1.4 1.7
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0.2 0.1 0.3 0.3 0.2 0.1 0.1 0 0 0
Long-Term Investments 61.2 21.7 0 18.1 6.8 0 0 22.4 41.3 8.9 24.7 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 29.7 26.9 0.1 6.8 0 3.8 3.6 1.0 2.0 4.0 2.6 4.8 5.5 5.7 11.7 21.0 40.9 46.8 4.7 5.1 7.9 0 0
Total Non-Current Assets 109.8 68.5 21.0 33.5 22.0 10.9 10.9 32.5 52.9 22.9 31.2 9.7 8.6 9.4 16.4 26.7 45.1 48.8 6.2 6.8 9 1.4 1.7
Total Assets 514.2 490.4 517.0 550 588.2 334.7 175.3 146.8 178.3 89.8 142.2 84.7 32.5 30.1 41.3 59.1 70.8 73.4 29.1 26.5 37.1 13.1 12.8
Current Liabilities
Account Payables 15.8 11.6 20.9 14.4 27.8 18.7 14.0 7.8 6.3 4.3 18.1 5.3 2.0 0.6 0.3 0.6 0.8 0.3 0.2 0.2 0.6 0.4 0.3
Short-Term Debt 40.1 35.4 0 0 0 30 38.6 33.7 35.1 28.2 0 0 0 0 0 0 0.0 0 0 0.1 0.2 0.3 0.3
Deferred Revenue 0 0 0 1.2 1.4 0.1 2.1 0.2 8.5 2.0 2.5 2.6 300 300 300 300 2,813.4 0 0 0 0 0 0
Other Current Liabilities 140.2 64.7 86.6 36.5 52.0 44.6 6.2 23.1 21.9 19.4 0.1 0.0 0 (0.0) 0 0 3.3 1.4 0.9 0.6 0.6 0.4 0.2
Total Current Liabilities 196.1 160.4 150.0 105.5 103.7 105.7 92.3 69.5 74.8 54.4 37.3 17.1 2.8 1.3 0.9 2.0 4.1 1.7 1.1 0.9 1.4 1.1 0.8
Non-Current Liabilities
Long-Term Debt 427.2 795.9 811.3 733.3 585.5 244.5 41.3 25.4 16.8 22.8 0 0 0 0 0 0 0 0 0 0 0.1 0.3 0.6
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 0 0 0.1 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.3 5.2 0.3 0.3 0.3 0.2 0.4 0.2
Total Non-Current Liabilities 437.2 806.0 822.5 739.1 591.4 248.3 44.7 28.1 19.7 33.9 18.7 21.2 0.3 0.3 0.3 0.3 5.2 0.3 0.3 0.3 0.3 0.7 0.8
Total Liabilities 633.3 966.4 972.5 844.6 695.1 354.0 137.0 97.6 94.5 88.3 55.9 38.3 3.1 1.6 1.2 2.3 9.3 2 1.4 1.2 1.7 1.8 1.6
Stockholders' Equity
Common Stock 2.1 2.1 2.1 1.9 1.8 1.8 1.5 1.1 1.0 0.7 0.4 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0 0 0 0 0
Retained Earnings (1,506.2) (1,770.0) (1,681.2) (1,454.6) (1,207.5) (1,023.4) (840.6) (732.0) (631.8) (566.1) (262.7) (249.3) (125.8) (104.7) (92.0) (75.0) (70.0) (58.5) (53.2) (48.4) (37.8) (30.1) (21.5)
Accumulated Other Comprehensive Income 0.0 0.9 1.3 0.0 0.2 0.0 0.0 (0.3) (0.2) (0.0) (0.0) 0.1 0 0 0 0 0 0 0 0 0 0 0
Total Stockholders' Equity (119.2) (475.9) (455.5) (294.6) (107.0) (19.3) 38.3 (732.0) (631.8) (566.1) 86.3 46.4 29.3 28.4 40.1 56.8 61.5 71.4 27.7 25.3 35.4 11.3 11.2
Total Liabilities & Equity 514.2 490.4 517.0 550 588.2 334.7 175.3 (634.4) (537.4) (477.8) 142.2 84.7 32.5 30.1 41.3 59.1 70.8 73.4 29.1 26.5 37.1 13.1 12.8
Debt Metrics
Total Debt 477.3 841.4 825.1 741.5 593.2 279.5 84.7 61.8 54.7 53.7 0 0 0 0 0 0 0.0 0 0 0.1 0.3 0.6 0.9
Net Debt 387.6 736.5 714.5 436.7 88.8 7.4 (29.5) 35.1 4.4 31.6 (41.1) (22.3) (8.8) (11.9) (13.8) (18.9) (8.4) (8.6) (12.3) (3.7) (3.3) (5.5) (1.8)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994
Operating Activities
Net Income 263.9 (88.9) (226.5) (247.1) (184.1) (182.8) (108.9) (101.3) (65.8) (55.1) (26.1) (21.1) (12.7) (16.9) (5.0) (5.5) (5.3) (4.8) (10.6) (7.7) (8.6) (6.9)
Depreciation & Amortization 1.4 1.2 1.7 1.4 0.8 0.7 0.7 0.8 0.7 0.5 0.9 1.0 1.1 1.2 1.0 0.7 0.5 0.5 0.6 0.5 0.6 0.6
Stock-Based Compensation 0 65.4 55.6 44.7 34.6 0 17.7 9.4 12.6 8.5 26.4 512.4 119.7 120.2 123.3 104.5 0 0 0 0 0 0
Change in Working Capital (56.9) (87.3) (32.4) (58.9) 8.1 26.9 (0.9) (3.5) 9.3 (7.6) 1.7 1.5 0.3 (1.2) 0.9 0.3 (0.3) (0.1) (0.5) 0.3 0.4 (0.3)
Other Non-Cash Items 121.5 57.5 106.5 98.1 (1.6) 18.0 1.7 0.9 0.9 0.6 0.2 0.5 0.0 0.5 (7.2) 7.4 0.2 0.2 0.2 0.1 (0.1) 0.1
Operating Cash Flow 329.9 (52.0) (95.1) (161.8) (142.2) (137.2) (89.6) (92.6) (41.1) (53.4) (23.3) (18.2) (11.2) (16.4) (10.2) (3.2) (4.9) (4.2) (10.3) (6.8) (7.7) (6.5)
Investing Activities
Capital Expenditure (2.5) (1.1) (2.2) (1.4) (2.4) (0.5) (0.3) (0.4) (0.3) (5.3) (0.5) (0.3) (0.1) (0.4) (2.6) (2.7) (1) (0.4) (1.1) (0.3) (0.2) (0.4)
Acquisitions (6.2) 0 0 0 0 0 0 0.4 0.0 0.0 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments (262.2) (266.8) (514.4) (244.3) (10.0) (49.8) (3.0) (62.6) (107.8) (14.1) (29.7) (18.9) (11.6) (8.1) (26.4) (10.8) (60.1) (13.6) (12.2) (37) (11.4) (13.4)
Sales/Maturities of Investments 256.6 320.5 385.1 117.4 28.2 43.5 81.3 67.7 43.5 42.7 18.7 16.4 20.1 19.8 49.5 15.1 13.3 19.8 23.5 10.1 14.3 5.2
Other Investing Activities 0.6 0 0 0 0 0.0 0 (0.4) (1.7) 0.1 (0.1) (0.1) (0.1) (0.1) (0.1) (0.1) 0.1 0 0 0 0 0
Investing Cash Flow (13.7) 52.6 (131.5) (128.2) 15.8 (6.9) 77.9 4.8 (66.4) 23.3 (11.5) (2.8) 8.4 11.2 20.4 1.5 (47.7) 5.8 10.2 (27.2) 2.7 (8.6)
Financing Activities
Net Debt Issuance (332.8) (1.7) 58.4 73.1 293.9 67.4 19.5 6.3 0.1 23.0 0 0 0 0 (0.0) (0.0) 0 (0.1) (0.2) (0.3) (0.3) (0.4)
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (8.8) (4.1) (26.2) 14.8 15.7 124.7 0 2.9 1.6 0.3 0 0 898.8 122.5 0 0 0 0.1 0 0 0 0.1
Financing Cash Flow (332.4) (5.8) 32.5 88.0 359.7 302.7 99.1 62.5 135.7 23.3 55.2 21.5 0.9 0.1 0.2 1.5 49 6.9 0.2 31.5 8.4 14.9
Cash Position
Net Change in Cash (103.3) (6.1) (193.8) (201.5) 233.4 158.6 87.4 (25.3) 28.2 (6.8) 20.3 0.5 (1.9) (5.0) 10.4 (0.2) (3.7) 8.5 0.1 (2.5) 3.4 (0.2)
Cash at Beginning 104.9 112.4 306.2 507.7 274.3 115.7 28.3 53.6 22.1 28.9 8.8 8.3 13.8 18.9 8.5 8.6 12.3 3.8 3.6 6.1 2.7 2.9
Cash at End 1.6 106.3 112.4 306.2 507.7 274.3 115.7 28.3 50.3 22.1 29.2 8.8 11.9 13.8 18.9 8.5 8.6 12.3 3.7 3.6 6.1 2.7
Free Cash Flow 327.4 (53.1) (97.3) (163.2) (144.5) (137.7) (89.9) (92.9) (41.5) (58.7) (23.8) (18.4) (11.2) (16.8) (12.8) (5.9) (5.9) (4.6) (11.4) (7.1) (7.9) (6.9)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994
Income Statement
Revenue 874.8 450.7 331.4 270.8 157.2 17.8 48.8 20.7 25.2 26.4 48.3 13.6 17.3 26.3 19.6 63.5 74.6 56.6 71.2 6.2 0.2 0.3 1.6 1.8 11.2 3.3 2.5 6.4 1 2.7 0.2 0.7
Gross Profit 855.8 438.2 326.8 264.2 149.9 16.1 44.7 20.2 23.5 23.7 46.4 13.5 17.2 26.2 19.6 63.4 70.0 56.6 71.2 6.2 0.2 0.3 1.6 1.8 11.2 3.3 3 6.9 1.6 (4.4) (6.3) (4.3)
Operating Income 341.0 (2.5) (103.7) (148.4) (177.7) (174.8) (99.5) (94.2) (57.4) (48.6) (39.4) (45.8) (30.7) (33.9) (49.6) (33.2) (13.7) (27.2) (32.3) (47.0) (27.2) (21.8) (12.7) (16.6) (5.0) (9.8) (8.1) (6) (12.3) (7.6) (9.1) (6.8)
Net Income 263.9 (88.9) (226.5) (247.1) (184.1) (182.8) (108.9) (101.3) (65.8) (55.1) (43.0) (45.2) (30.1) (39.1) (56.9) (32.7) (13.5) (24.7) (29.1) (43.6) (26.1) (21.1) (12.7) (16.9) (5.0) (11.6) (5.3) (4.8) (10.6) (7.7) (8.6) (6.9)
EPS (Diluted) 1.21 -0.43 -1.18 -1.33 -1.03 -1.09 -0.94 -0.98 -0.78 -0.75 -0.59 -0.68 -0.55 -0.79 -1.26 -0.73 -0.35 -0.65 -0.89 -1.50 -1.01 -1.00 -0.72 -0.96 -0.28 -0.61 -0.34 -0.34 -0.77 -0.69 -0.96 -1.02
Balance Sheet
Cash & Equivalents 89.7 104.9 110.6 304.8 504.4 272.1 114.2 26.7 50.3 22.1 41.1 22.3 8.8 11.9 13.8 18.9 8.5 8.6 12.3 3.8 3.6 6.1 2.7
Total Assets 514.2 490.4 517.0 550 588.2 334.7 175.3 146.8 178.3 89.8 142.2 84.7 32.5 30.1 41.3 59.1 70.8 73.4 29.1 26.5 37.1 13.1 12.8
Total Debt 477.3 841.4 825.1 741.5 593.2 279.5 84.7 61.8 54.7 53.7 0 0 0 0 0 0 0.0 0 0 0.1 0.3 0.6 0.9
Stockholders' Equity (119.2) (475.9) (455.5) (294.6) (107.0) (19.3) 38.3 (732.0) (631.8) (566.1) 86.3 46.4 29.3 28.4 40.1 56.8 61.5 71.4 27.7 25.3 35.4 11.3 11.2
Cash Flow
Operating Cash Flow 329.9 (52.0) (95.1) (161.8) (142.2) (137.2) (89.6) (92.6) (41.1) (53.4) (23.3) (18.2) (11.2) (16.4) (10.2) (3.2) (4.9) (4.2) (10.3) (6.8) (7.7) (6.5)
Capital Expenditure (2.5) (1.1) (2.2) (1.4) (2.4) (0.5) (0.3) (0.4) (0.3) (5.3) (0.5) (0.3) (0.1) (0.4) (2.6) (2.7) (1) (0.4) (1.1) (0.3) (0.2) (0.4)
Free Cash Flow 327.4 (53.1) (97.3) (163.2) (144.5) (137.7) (89.9) (92.9) (41.5) (58.7) (23.8) (18.4) (11.2) (16.8) (12.8) (5.9) (5.9) (4.6) (11.4) (7.1) (7.9) (6.9)